Back To Search Results

Castor Oil

Editor: Jayson Tripp Updated: 5/24/2024 7:10:05 PM

Indications

Castor oil is a vegetable oil derived from the Ricinus communis plant, which is common in the Eastern areas of the world. Castor oil is not frequently used in modern medicine, but its utility is justified when patients prefer a more natural approach. As castor oil is derived from the plant R communis, many patients may prefer its use due to its natural growth, which inherently seems nontoxic and safer than traditional medicine.[1] With more scientific literature on castor oil's mechanism of action, adverse effect profile, and toxicity, the treatment is now completely safe and effective according to the US Food and Drug Administration (FDA) standards. 

FDA-Approved Indications

Despite its traditional use, the FDA has only approved the use of castor oil as a stimulative laxative for the temporary relief of occasional constipation. However, its use has declined over the years as research has produced more effective laxatives with fewer adverse effects. Castor oil can be beneficial for medical procedures, particularly in diagnostic tests such as colonoscopies, where bowel prep is essential before performing the procedure.[2] Although castor oil may be used for bowel evacuation, patients typically experience better results and satisfaction with other laxatives such as sennosides, polyethylene glycol (PEG), and bisacodyl. In a study comparing castor oil to senna syrup, the senna group had fewer adverse effects and better bowel preparation.[3] Additionally, a meta-analysis suggests that castor oil is useful for capsule colonoscopy, improving completion rates and polyp detection

The treatment is safe, but more studies are needed to confirm these findings.[4][5] A retrospective study compared a 2-L PEG with castor oil (PEG-CaO) solution to the standard 4-L split PEG solution for colonoscopy preparation in hospitalized patients. The group receiving the 2-L PEG-CaO solution scored higher on the Boston Bowel Preparation Scale (BBPS), indicating better bowel cleansing. Additionally, this group had a higher success rate of adequate bowel preparation and experienced fewer adverse effects than the 4-L PEG group. These findings suggest that the 2-L PEG-CaO solution is a viable alternative for bowel preparation before colonoscopy in hospitalized patients.[6]

Off-Label Uses

Although other uses of castor oil exist, these indications are not FDA-approved. These uses include wound healing, arthritis, headache, menstrual cramps, and labor induction. While these uses have been common in alternative medicine for hundreds of years, scientific evidence is insufficient to support these claims in modern medicine.[7] With chronic idiopathic constipation being one of the most common gastrointestinal complaints, castor oil is of significant benefit.[8] 

A study examined the use of castor oil for labor induction in 70 women with 1 prior cesarean section. While castor oil shows promise, further research is needed to confirm its safety.[9] A review assessed various pharmacological agents, mechanical methods, and complementary approaches for cervical ripening and labor induction. Although prostaglandins, oxytocin, and misoprostol are commonly used and supported by research, complementary methods, such as castor oil, lack sufficient evidence for efficacy and safety in hospital settings.[10]

Another study summarizes the potential therapeutic benefits of castor oil in managing blepharitis, dry eye disease, and meibomian gland dysfunction. However, additional research is needed to understand the therapeutic potential thoroughly.[11]

Mechanism of Action

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Mechanism of Action

The main chemical with laxative properties in castor oil is ricinoleic acid. In the intestine, lipase breaks down castor oil into ricinoleic acid, which activates EP3 and EP4 prostanoid receptors in smooth muscle cells. This activation creates a transient calcium surge, causing propulsion in the intestine. Due to this mechanism of action, castor oil falls into the stimulant laxative category, similar to bisacodyl and sennosides. EP3 and EP4 prostanoid receptors are also present in the uterus, suggesting the potential use of castor oil for labor induction; however, more research is necessary on this subject.[12]

Pharmacokinetics

Absorption: Following administration, castor oil undergoes a process where lipases in the intestinal lumen release ricinoleic acid, which is then absorbed in the intestine. Preclinical research indicates that the absorption of castor oil is inversely proportional to the dosage administered. However, absorption is nearly complete at smaller doses, such as 4 g. The onset of action is usually within 1 to 3 hours.

Distribution: The information regarding the volume of distribution is unavailable.

Metabolism: Castor oil is broken down by pancreatic enzymes within the small intestine, which liberates glycerol and ricinoleic acid. Ricinoleic acid then undergoes systemic metabolism, excreting the resulting metabolites. As expected, pancreatic and intestinal lipases facilitate the degradation of fatty acids.

Excretion: The excretion of castor oil in feces varies between 11.4% (for a 10 g dose) and 86% (for a 44.4 g dose).

Administration

Available Dosage Forms and Strengths

Castor oil is taken orally and must be broken down by intestinal lipases to produce the stimulant laxative effects. Castor oil is available as a 100% oral solution and can be purchased over the counter.

Adult Dosage

An appropriate daily dosage for an adult male is 15 to 60 mL. Taking castor oil with juice may improve the taste.

Specific Patient Populations

Hepatic impairment: The product label does not provide dosage adjustments for castor oil; therefore, it should be used cautiously.

Renal impairment: The product label does not provide dosage adjustments for castor oil; therefore, it should be used cautiously.

Pregnancy considerations: In the early 1950s, over half of academic obstetrical departments in the United States administered castor oil alone or combined with soap suds enemas. With the advent of pharmacological interventions, castor oil is no longer used in hospitals in high-income countries. However, the general public still uses the treatment in low-resource settings. Potential complications include meconium staining and maternal electrolyte abnormalities due to diarrhea.[10] Ingesting castor oil during pregnancy may induce labor, so use as a laxative is contraindicated.

Breastfeeding considerations: Castor oil is a potent stimulant laxative. Homeopathic preparations of castor oil are sometimes used to reduce milk flow or as a galactagogue, although no scientifically valid clinical trials support these uses. Some preparations can be toxic to infants. Galactagogues should not replace evaluation and counseling on modifiable factors affecting milk production. No data exist on the excretion of castor plant components into breast milk or their safety and efficacy in nursing mothers or infants. Due to the lack of information, other laxatives may be preferred during lactation. The administration of castor oil to infants is risky and should be avoided due to adverse effects.[13]

Pediatric patients: Castor oil is frequently used in teas in newborn Haitian children to facilitate the passage of meconium stool or treat minor illnesses. Although typically administered in small doses, larger volumes are occasionally used, leading to significant risks. This traditional practice is underdocumented and can result in adverse outcomes. Consequently, administering castor oil to newborns is not advisable and should be avoided.[14] As per the product labeling, adults and children aged 12 and older can take 1 to 4 tablespoons of castor oil daily, as advised by a clinician. The recommended dosage for children between the ages of 2 and 12 is 1 to 3 teaspoons daily or as directed by a clinician.

Older patients: Castor oil should be used cautiously in older patients due to the increased risk of adverse effects related to potential renal and cardiac impairment, as well as possible fluid and electrolyte imbalance.

Adverse Effects

The adverse effects of castor oil are a common reason for its infrequent use in conventional medicine. In a study comparing castor oil to sennosides, castor oil was more likely to cause abdominal cramping, vomiting, bloating, and dizziness. Far fewer adverse effects occurred with the use of other laxatives.[3]

Few studies have also proposed that long-term use of a stimulant laxative may create a cathartic colon due to anatomic changes. However, more recent evidence suggests that a "cathartic colon" is not an actual condition.[15] Additionally, a study identified castor oil, often used in lip care products, as a potential trigger for allergic contact dermatitis. Patients with sensitive skin who use castor oil-containing lip balms or glosses may develop symptoms like pruritus and erythema on the lips. While not universally applicable, these findings suggest that some individuals are susceptible to allergic reactions to castor oil.[16]

Drug-Drug Interactions

The use of stimulant laxatives alongside castor oil is not recommended due to the risk of adverse effects, particularly gastrointestinal complications.

Contraindications

With castor oil affecting smooth muscle, recommendations advise against its use in pregnancy, as this can lead to premature contractions. Contraindications to stimulant laxatives also include various abdominal pathologies such as gastrointestinal obstruction, appendicitis, perforation, and inflammatory bowel disease.[17]

Monitoring

As with any laxative, it is advisable to monitor for electrolyte disturbances and acid-base disorders. Imbalances may occur due to the loss of bicarbonate, water, and electrolytes, which can worsen with diarrhea. Physical examination signs in the patient may include rapid breathing, confusion, sleepiness, vomiting, and weakness, especially in cases of electrolyte disturbances and acid-base imbalances. These issues can potentially be lethal if not addressed immediately. 

The treating clinician should also monitor patients for laxative abuse. Patients with anorexia nervosa or bulimia are especially at risk as they may try to decrease weight through laxative abuse. Such abuse can be detrimental due to the loss of minerals, nutrition, and electrolytes.[18]

Toxicity

Signs and Symptoms of Overdose

The castor plant, R communis, is known to contain a toxic chemical called ricin. If an individual eats Ricinus seeds directly, the ricin toxin can take effect in as little as 4 to 12 hours. Signs and symptoms of ricin toxicity include gastrointestinal bleeding, shock, pulmonary edema, and inflammation. These symptoms occur due to the inactivating effect of ricin toxin on ribosomes, which renders the body unable to create proteins. Castor bean ingestion can result in two distinct clinical effects—acute and late-phase manifestations.

During the acute phase, patients commonly experience gastrointestinal symptoms. Conversely, the late phase is characterized by cytotoxic effects on the kidney, liver, and adrenal gland, typically manifesting 2 to 5 days post-exposure. Ricin toxicity affects multiple body systems, often presenting with fever as a prominent clinical feature. Fever onset can occur within 30 minutes to 2 hours after ingesting 1 to 4 beans.[19] Due to ricin's water-soluble properties, the castor oil extraction process negates these toxic properties.[20] Castor oil is purified with ricin during the extraction process. Castor oil is completely safe for human consumption with minimal toxic effects in both acute and chronic settings and has demonstrated no genotoxic effects. Castor oil is also used widely for nonmedical purposes, such as lubrication, cosmetics, and coatings.[2] 

Management of Overdose

Clinicians need to provide supportive care to patients during ricin toxicity, as a specific antidote for castor oil toxicity is currently not available. Replenishing intravenous fluids and electrolytes is essential for managing gastroenteritis.

Enhancing Healthcare Team Outcomes

The healthcare team is responsible for maintaining professionalism, ethics, and respect for the patient's decisions regarding their care. Given the natural quality of castor oil, many patients may prefer this treatment option. With increased scientific research regarding castor oil and its longstanding historical use, clinicians can confidently consider prescribing this medication. However, the clinician must conduct a thorough examination and appropriate diagnosis before determining whether castor oil is suitable, considering the various contraindications that may exist. 

After prescribing the medication, monitoring the patient involves observing for adverse effects. As the primary contact for patient care, nurses can assist the physician in identifying any abnormalities in patient behavior, including signs of electrolyte imbalances, acid-base disorders, or dehydration. Lastly, a pharmacist can aid the team with appropriate dosing and drug interactions. Castor oil is a potent laxative, so the absorption of other oral drugs may be severely affected. Overall, the interprofessional healthcare team must collaborate to ensure positive outcomes.

References


[1]

Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner journal. 2012 Spring:12(1):45-56     [PubMed PMID: 22438782]

Level 1 (high-level) evidence

[2]

. Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate. International journal of toxicology. 2007:26 Suppl 3():31-77. doi: 10.1080/10915810701663150. Epub     [PubMed PMID: 18080873]

Level 3 (low-level) evidence

[3]

Ghazikhanlou Sani K, Jafari MR, Shams S. A comparison of the efficacy, adverse effects, and patient compliance of the sena-graph®syrup and castor oil regimens for bowel preparation. Iranian journal of pharmaceutical research : IJPR. 2010 Spring:9(2):193-8     [PubMed PMID: 24363727]


[4]

Deding U, Jensen SS, Schelde-Olesen B, Kaalby L, Bjørsum-Meyer T, Koulaouzidis A. Castor Oil in Bowel Preparation Regimens for Colon Capsule Endoscopy: A Systematic Review with Meta-Analysis. Diagnostics (Basel, Switzerland). 2022 Nov 15:12(11):. doi: 10.3390/diagnostics12112795. Epub 2022 Nov 15     [PubMed PMID: 36428855]

Level 1 (high-level) evidence

[5]

Mizukami K, Inumaru Y, Akiyama H, Fukuda K, Okamoto K, Fujioka T, Okimoto T, Murakami K. Efficacy of the Castor Oil-Filled Capsule Method as Preparation for Colon Capsule Endoscopy. Digestion. 2023:104(5):409-414. doi: 10.1159/000529648. Epub 2023 Apr 18     [PubMed PMID: 37071981]


[6]

Xiong Z, Fang Y, Feng F, Cheng Y, Huo C, Huang J. 2L polyethylene glycol combined with castor oil versus 4L polyethylene glycol for bowel preparation before colonoscopy among inpatients. Medicine. 2023 Jul 21:102(29):e34294. doi: 10.1097/MD.0000000000034294. Epub     [PubMed PMID: 37478260]


[7]

Marwat SK, Rehman F, Khan EA, Baloch MS, Sadiq M, Ullah I, Javaria S, Shaheen S. Review - Ricinus cmmunis - Ethnomedicinal uses and pharmacological activities. Pakistan journal of pharmaceutical sciences. 2017 Sep:30(5):1815-1827     [PubMed PMID: 29084706]


[8]

Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. The Medical journal of Australia. 2018 Jul 16:209(2):86-91     [PubMed PMID: 29996755]


[9]

Bayoumi YA, Alalfy M, Sharkawy M, Ali AS, Gouda HM, Hatem DL. Castor oil for labor initiation in women with a previous cesarean section: a double-blind randomized study. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2022 Dec:35(25):8945-8951. doi: 10.1080/14767058.2021.2008350. Epub 2021 Dec 9     [PubMed PMID: 34886746]

Level 1 (high-level) evidence

[10]

Sanchez-Ramos L, Levine LD, Sciscione AC, Mozurkewich EL, Ramsey PS, Adair CD, Kaunitz AM, McKinney JA. Methods for the induction of labor: efficacy and safety. American journal of obstetrics and gynecology. 2024 Mar:230(3S):S669-S695. doi: 10.1016/j.ajog.2023.02.009. Epub 2023 Jul 13     [PubMed PMID: 38462252]


[11]

Sandford EC, Muntz A, Craig JP. Therapeutic potential of castor oil in managing blepharitis, meibomian gland dysfunction and dry eye. Clinical & experimental optometry. 2021 Apr:104(3):315-322. doi: 10.1111/cxo.13148. Epub 2021 Mar 10     [PubMed PMID: 33037703]


[12]

Tunaru S, Althoff TF, Nüsing RM, Diener M, Offermanns S. Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors. Proceedings of the National Academy of Sciences of the United States of America. 2012 Jun 5:109(23):9179-84. doi: 10.1073/pnas.1201627109. Epub 2012 May 21     [PubMed PMID: 22615395]

Level 3 (low-level) evidence

[13]

. Castor. Drugs and Lactation Database (LactMed®). 2006:():     [PubMed PMID: 30000935]


[14]

Jean Baptiste W, Casseus M, Dev A, Joseph P, Wright PF. The dangers of castor oil tea in neonates in rural Haiti: A case report. Frontiers in pediatrics. 2023:11():877550. doi: 10.3389/fped.2023.877550. Epub 2023 Mar 6     [PubMed PMID: 36950175]

Level 3 (low-level) evidence

[15]

Portalatin M, Winstead N. Medical management of constipation. Clinics in colon and rectal surgery. 2012 Mar:25(1):12-9. doi: 10.1055/s-0032-1301754. Epub     [PubMed PMID: 23449608]


[16]

Pal B, Kumari S, Kumari A, Singh SK, Babbar H. Allergic contact dermatitis to lip care cosmetic products - a systematic review. Cutaneous and ocular toxicology. 2024 Mar:43(1):13-21. doi: 10.1080/15569527.2023.2275022. Epub 2023 Oct 30     [PubMed PMID: 37904533]

Level 1 (high-level) evidence

[17]

Xing JH, Soffer EE. Adverse effects of laxatives. Diseases of the colon and rectum. 2001 Aug:44(8):1201-9     [PubMed PMID: 11535863]


[18]

Roerig JL, Steffen KJ, Mitchell JE, Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010 Aug 20:70(12):1487-503. doi: 10.2165/11898640-000000000-00000. Epub     [PubMed PMID: 20687617]


[19]

Al-Tamimi FA, Hegazi AE. A case of castor bean poisoning. Sultan Qaboos University medical journal. 2008 Mar:8(1):83-7     [PubMed PMID: 21654963]

Level 3 (low-level) evidence

[20]

Worbs S, Köhler K, Pauly D, Avondet MA, Schaer M, Dorner MB, Dorner BG. Ricinus communis intoxications in human and veterinary medicine-a summary of real cases. Toxins. 2011 Oct:3(10):1332-72. doi: 10.3390/toxins3101332. Epub 2011 Oct 24     [PubMed PMID: 22069699]

Level 3 (low-level) evidence